Search

everythinglearnresearchcommunity

for

Search:↓

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Alopecia areata treatment varies, with no optimal method established yet.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Triamcinolone acetonide is more effective than cryotherapy for hair regrowth in alopecia areata but has different side effects.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Current treatments for alopecia show no significant long-term benefits.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The 308-nm Excimer laser is effective and safe for treating patchy alopecia areata in children.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Baricitinib is effective and safe for treating severe alopecia areata.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

More research is needed to understand alopecia areata severity.